Price loading...

The 2023-2028 Outlook for Anxiety Disorder Treatments in the United States

Price data last checked 92 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
09 November 2022

Similar Products You Might Like

The 2023-2028 Outlook for Anxiety Disorder Therapeutics in the United States
99% match

The 2023-2028 Outlook for Anxiety Disorder Therapeutics in the United States

£520.00 25 Jan 2026
The 2023-2028 Outlook for Anxiety Disorders and Depression Treatments in the United States
99% match

The 2023-2028 Outlook for Anxiety Disorders and Depression Treatments in the United States

£520.00 25 Jan 2026
The 2023-2028 Outlook for Anxiety Disorders and Depression in the United States
98% match

The 2023-2028 Outlook for Anxiety Disorders and Depression in the United States

£520.00 22 Jan 2026
The 2023-2028 Outlook for Antidepressants for Anxiety Disorders in the United States
98% match

The 2023-2028 Outlook for Antidepressants for Anxiety Disorders in the United States

£520.00 28 Jan 2026
The 2023-2028 Outlook for Stress Management Treatments in the United States
97% match

The 2023-2028 Outlook for Stress Management Treatments in the United States

£520.00 31 Jan 2026
The 2023-2028 Outlook for Schizophrenia Treatments in the United States
97% match

The 2023-2028 Outlook for Schizophrenia Treatments in the United States

£520.00 25 Jan 2026
The 2023-2028 Outlook for Autism Spectrum Disorder Therapeutics in the United States
97% match

The 2023-2028 Outlook for Autism Spectrum Disorder Therapeutics in the United States

£520.00 12 Jan 2026
The 2023-2028 Outlook for Amyloidosis Treatments in the United States
96% match

The 2023-2028 Outlook for Amyloidosis Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Personal Therapy Products in the United States
96% match

The 2023-2028 Outlook for Personal Therapy Products in the United States

£520.00 24 Jan 2026
The 2023-2028 Outlook for Antidepressants for Major Depressive Disorders in the United States
96% match

The 2023-2028 Outlook for Antidepressants for Major Depressive Disorders in the United States

£520.00 27 Jan 2026
The 2023-2028 Outlook for Asthma Treatments in the United States
96% match

The 2023-2028 Outlook for Asthma Treatments in the United States

£520.00 22 Jan 2026
The 2023-2028 Outlook for Autism Therapies in the United States
96% match

The 2023-2028 Outlook for Autism Therapies in the United States

£520.00 12 Jan 2026
The 2023-2028 Outlook for Insomnia Therapeutics in the United States
96% match

The 2023-2028 Outlook for Insomnia Therapeutics in the United States

£520.00 15 Jan 2026
The 2023-2028 Outlook for Antipsychotic Drugs for Schizophrenia in the United States
96% match

The 2023-2028 Outlook for Antipsychotic Drugs for Schizophrenia in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Optic Nerve Disorders Treatments in the United States
96% match

The 2023-2028 Outlook for Optic Nerve Disorders Treatments in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for Atopic Dermatitis Treatments in the United States
96% match

The 2023-2028 Outlook for Atopic Dermatitis Treatments in the United States

£520.00 23 Jan 2026
The 2023-2028 World Outlook for Stress Management Treatments
96% match

The 2023-2028 World Outlook for Stress Management Treatments

£795.00 24 Jan 2026
The 2023-2028 Outlook for Sarcopenia Treatments in the United States
96% match

The 2023-2028 Outlook for Sarcopenia Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Motion Sickness Treatments in the United States
96% match

The 2023-2028 Outlook for Motion Sickness Treatments in the United States

£520.00 31 Jan 2026
The 2023-2028 Outlook for Benzodiazepine Drugs in the United States
96% match

The 2023-2028 Outlook for Benzodiazepine Drugs in the United States

£520.00 10 Feb 2026
The 2023-2028 Outlook for Respiratory Disorder Treatments in the United States
96% match

The 2023-2028 Outlook for Respiratory Disorder Treatments in the United States

£520.00 22 Jan 2026
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in the United States
96% match

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Air Treatment Products in the United States
96% match

The 2023-2028 Outlook for Air Treatment Products in the United States

£520.00 25 Jan 2026
The 2023-2028 Outlook for Allergy Treatments in the United States
96% match

The 2023-2028 Outlook for Allergy Treatments in the United States

£520.00 27 Jan 2026